Skip to content
Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Us Securely

Fees | Join Our Practice

  • Home
  • Dr. Tashko
    • Profile
    • My Philosophy
    • Featured in Montgomery Magazine
    • Featured in Washingtonian
    • Publications
  • Reviews
  • Benefits
    • Personalized & Integrative Care
    • Our Unique Approach
    • FAQs
  • Services
    • Endocrinology
    • Diabetes
    • Lipidology
    • Hypertension
    • Weight Loss
    • Heart
    • Women’s Health
    • Testosterone, TRT
    • Thyroid
    • Parathyroid
    • Adrenal
    • Pituitary
    • Gynecomastia
    • PCOS
    • Osteoporosis
    • Calcium
    • Longevity
    • Clinical Trials
    • Energy Metabolism
    • Fitness
    • More…
  • Become a Patient
    • Join Our Practice
    • Fees
    • A Letter to My Patients
  • Resources
    • Articles and Posts
    • Key Clinical Trials
    • Clinical Guidelines
    • Personal Interests
    • Search 🔎
  • Contact Us

Holistic Lipid Care in Maryland

  • PCSK9 Inhibitors: Smarter Cholesterol Control for Long-Term Heart Health

    PCSK9 Inhibitors: Smarter Cholesterol Control for Long-Term Heart Health

    Blocking PCSK9 gives the liver more power to remove cholesterol from the blood. PCSK9 inhibitors such as evolocumab, alirocumab, and inclisiran deliver large LDL drops and better heart protection with minimal side effects. These therapies now anchor advanced lipid management for high-risk or statin-intolerant patients.

    Published

    October 22, 2025
    Categorized as Drug Information, Heart Health, Insights from Dr. Tashko, Lipid Health
  • Coronary CT Angiography: Seeing the Heart Vessels Before Trouble Starts

    Coronary CT Angiography: Seeing the Heart Vessels Before Trouble Starts

    Coronary CT angiography provides a detailed look inside the heart’s arteries before symptoms appear. This noninvasive scan detects both calcified and soft plaque, helping guide prevention tailored to each patient’s risk profile. When interpreted in a broader metabolic context, it becomes a powerful tool for long-term heart and vascular health.

    Published

    October 19, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health
  • Understanding Non-Calcified and Calcified Plaque in Heart Disease

    Understanding Non-Calcified and Calcified Plaque in Heart Disease

    Plaque type matters as much as plaque amount. Soft plaques rupture easily and trigger heart attacks. Hard plaques are older and more stable. Calcium scoring and CT angiography together reveal true cardiovascular risk. Understanding these differences helps guide prevention. With clear imaging and targeted metabolic testing, patients can take focused steps to protect arteries and maintain long-term heart health through a balanced and proactive approach.

    Published

    October 16, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health
  • Refined Sugars and the Rise of Small LDL Particles

    Refined Sugars and the Rise of Small LDL Particles

    Refined sugars raise blood sugar, drive insulin resistance, and increase harmful small LDL particles. These dense cholesterol particles slip into artery walls, fueling heart risk. Even with normal cholesterol, patients may face hidden danger. Discover how advanced lipid testing and smarter diet choices uncover risks and lower cardiovascular burden for lasting health.

    Published

    September 23, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health, Nutritional Guidance
  • How Obesity Can Increase Small LDL Particle Number

    How Obesity Can Increase Small LDL Particle Number

    Obesity often increases the number of small LDL particles, which are more harmful than standard LDL cholesterol. These tiny particles stay longer in circulation, oxidize easily, and fuel artery plaque. Insulin resistance, high triglycerides, low HDL cholesterol, and inflammation all contribute. Advanced lipid testing reveals these hidden risks. Personalized care can reduce weight, improve insulin sensitivity, and shift cholesterol toward a safer pattern for heart health.

    Published

    September 11, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health, Obesity Care
  • Endothelial Function and Dysfunction: The Vascular Balancing Act

    Endothelial Function and Dysfunction: The Vascular Balancing Act

    The endothelium lines your blood vessels and keeps them healthy. When it becomes dysfunctional, inflammation, stiffness, and plaque can silently develop. This article explains how endothelial dysfunction contributes to heart disease and metabolic conditions, and how personalized strategies can reverse it through lifestyle changes, advanced testing, and targeted therapies.

    Published

    June 18, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health
  • How the ASCVD Risk Calculator Guides Smart Prevention

    How the ASCVD Risk Calculator Guides Smart Prevention

    The ASCVD Risk Calculator estimates 10-year heart and stroke risk using basic lab and clinical data. But numbers alone don’t tell the full story. Learn how thoughtful care, deeper lipid testing, and an individualized strategy can guide smarter prevention—especially for those with silent risks or early metabolic changes.

    Published

    June 6, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health
  • Why Non-HDL Cholesterol Still Matters

    Why Non-HDL Cholesterol Still Matters

    Non-HDL cholesterol includes all dangerous cholesterol types, not just LDL. This makes it a stronger tool for predicting cardiovascular risk—especially in patients with diabetes, obesity, or high triglycerides. It plays a key role in individualized, comprehensive lipid care focused on preventing heart disease before it starts.

    Published

    May 21, 2025
    Categorized as Hypertriglyceridemia, Insights from Dr. Tashko, Insulin Resistance, Lipid Health
  • Lower LDL Cholesterol May Protect the Brain from Dementia

    Lower LDL Cholesterol May Protect the Brain from Dementia

    A New Look at LDL and Cognitive Health We often hear about bad cholesterol—low-density lipoprotein cholesterol (LDL-C)—as a major cause of heart disease. But what about its role in brain health? A new study from a large university hospital network in South Korea helps clarify the link between LDL-C levels and dementia risk. The results are both surprising and reassuring. The Study at a Glance Researchers analyzed data from 11 university hospitals using a shared…

    Published

    April 11, 2025
    Categorized as Cognitive Health, Dr. Tashko’s Key Clinical Trials, Lipid Health
  • Lipid Changes After Alcohol Cessation: What You Need to Know

    Lipid Changes After Alcohol Cessation: What You Need to Know

    A recent study, published in JAMA Network Open in March 2025, examined how changes in alcohol consumption affect cholesterol levels. Researchers analyzed over 57,000 adults undergoing annual health checkups and found that quitting alcohol led to increased LDL (bad cholesterol) and decreased HDL (good cholesterol).

    Published

    March 17, 2025
    Categorized as Dr. Tashko’s Key Clinical Trials, Lipid Health
  • Why Do Some People With Very High Lipoprotein(a) Have Clean Arteries?

    Why Do Some People With Very High Lipoprotein(a) Have Clean Arteries?

    Lipoprotein(a), or Lp(a), has been a major focus in cardiovascular research for years. Elevated levels are strongly linked to increased risks of heart attacks, strokes, and atherosclerosis (plaque buildup in arteries). Yet, a paradox exists—some individuals with very high Lp(a) levels have clean coronary arteries and show no signs of cardiovascular disease (CVD).

    Published

    March 9, 2025
    Categorized as Heart Health, Insights from Dr. Tashko, Lipid Health

The only US physician board-certified in:

❥ Endocrinology, Diabetes and Metabolism

❥ Obesity Medicine

❥ Hypertension

❥ Lipidology

Dr. Tashko’s badge from the Better Business Bureau displays an “Accredited Business” seal with an A+ rating as of July 9, 2025 for GT Health practice. The design features the BBB torch logo on the left and a clickable prompt for profile access on the right, reinforcing professional credibility, transparency, and excellence in patient care and business ethics.
🗨️ Text Our Office Securely

T

301.658.3586

F

240.427.4704

E

admin@GThealth.net

15204 Omega Drive
Suite 240
Rockville, MD 20850

Dr. Tashko is quadruple board-certified in endocrinology, lipidology, hypertension, and obesity medicine. He specializes in diabetes, metabolism, and longevity care, offering integrative, evidence-based solutions for insulin resistance, metabolic syndrome, prediabetes, obesity, and weight management.

He provides advanced cardiovascular prevention and lipid management, focusing on precise control of blood pressure, cholesterol, and triglycerides.

His endocrine expertise covers thyroid and parathyroid disorders, pituitary and adrenal conditions, growth hormone deficiency, Cushing’s syndrome, hyperprolactinemia, and bone health issues such as osteopenia and osteoporosis.

Dr. Tashko also treats low testosterone (TRT), gynecomastia, and polycystic ovary syndrome (PCOS). Each patient receives comprehensive, personalized care centered on metabolic and hormonal balance.

GT Health is based in Rockville, Montgomery County, MD, and serves patients throughout Bethesda, Chevy Chase, Potomac, Gaithersburg, Germantown, Frederick, Silver Spring, Howard County, Anne Arundel, Northern Virginia, and the Eastern Shore. GT Health provides concierge endocrine and metabolic care in Rockville and across Maryland through secure virtual visits.

Medical Conditions
  • Facebook
  • Google
  • LinkedIn
  • Twitter

Copyright

© 2017–2026

Gerti Tashko, M.D.

All Rights Reserved.

“In him all things hold together.”
— Col 1:17